Research Article
Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
Table 2
Titratable vs. nontitratable insulin infusion patients.
| | Results | | Nontitratable (n = 87) | Titratable (n = 64) | value |
| | Primary endpoints | | Duration of insulin infusion (hours), mean | 34.3 | 29.1 | 0.16 | | ICU LoS (days), mean | 3.9 | 3.1 | 0.20 | | Hospital LoS (days), mean | 10.4 | 6.4 | 0.03 |
| | Secondary endpoints | | ICU survival (%) | 95.4 | 98.4 | 0.30 | | Hospital survival (%) | 92.0 | 98.4 | 0.08 |
| | Safety endpoints | | Hypoglycemia (%) | 46.0 | 20.6 | <0.01 | | Hypokalemia (%) | 70.1 | 62.5 | 0.14 |
|
|
n = number.
|
